SureTrader
Home > Boards > US Listed > Medical - Drugs > Oramed Pharmaceuticals (ORMP)

Been following this one for a couple of

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
humpback Member Profile
 
Followed By 8
Posts 1,591
Boards Moderated 0
Alias Born 04/09/07
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/5/2016 12:35:46 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 8/4/2016 4:56:43 PM
Oramed Receives Additional $4 Million Milestone Payment From HTIT "PR Newswire (US)" - 8/2/2016 9:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/28/2016 4:33:26 PM
Oramed Reports Additional Phase IIb Oral Insulin Study Data Demonstrating Significant Lowering of Glucose Levels vs Placebo "PR Newswire (US)" - 7/28/2016 8:15:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/27/2016 10:15:29 AM
Oramed Appoints Dr. Roy Eldor as Chief Medical Director "PR Newswire (US)" - 7/26/2016 9:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 7/6/2016 3:35:39 PM
Oramed Announces $6.5 Million Milestone Payment from HTIT "PR Newswire (US)" - 6/21/2016 9:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/16/2016 10:19:48 AM
Oramed to Present at the American Diabetes Association 76th Scientific Sessions "PR Newswire (US)" - 6/9/2016 8:15:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/23/2016 5:14:23 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/23/2016 11:15:52 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/18/2016 10:56:33 AM
Oramed Announces Positive Top-Line Results from Phase IIb Oral Insulin Study "PR Newswire (US)" - 5/18/2016 7:25:00 AM
Oramed to Present at Oppenheimer Annual Israeli Conference "PR Newswire (US)" - 5/16/2016 9:49:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/12/2016 5:35:55 PM
Oramed Patent Being Granted in China for Oral Administration of Proteins "PR Newswire (US)" - 5/11/2016 8:15:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/4/2016 8:35:21 AM
Oramed to Present at PIONEERS 2016, Presented by Joseph Gunnar "PR Newswire (US)" - 4/28/2016 8:15:00 AM
Oramed Receives Patent Term Adjustment Extending the Term of Its U.S. Patent "PR Newswire (US)" - 4/12/2016 8:15:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 4/6/2016 3:30:17 PM
Oramed Completes Phase IIb Oral Insulin Study "PR Newswire (US)" - 4/5/2016 8:15:00 AM
Oramed Patent Granted in India for Oral Administration of Proteins "PR Newswire (US)" - 3/29/2016 8:15:00 AM
Prospectus Filed Pursuant to Rule 424(b)(7) (424b7) "Edgar (US Regulatory)" - 3/1/2016 1:34:46 PM
humpback   Friday, 10/31/08 03:01:57 PM
Re: axelvento post# 61
Post # of 477 
Been following this one for a couple of years now. Just bought back in. Do you think that this company has a chance to be bought out by a larger pharmaceutical company?

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist